Pre-market · Regular session opens 9:30 AM ET
Last update: Jun 30, 2026, 3:54 AM ET
Revolution Medicines, Inc. (RVMD) — What Changed
$192.62+10.54 (+5.79%) vs yesterday's close
Jun 30, 2026 6:27 AM ET·NASDAQ Global Select·Pre-market·CEO: Mark A. Goldsmith·616 employees
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cance…
🔔Major Change Detected
Price Move
+5.79%
1-Day Change
Volume Confirmation
1.54x
vs 30D Average
Catalyst
Earnings Miss
Material / Earnings
Peer Context
In Line With Peers
No peer data
Signal Quality
High
Confidence Score
83/100
BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.
1. What Changed Since Last Close
V›
Price Move UpHighHigh
Jun 29+5.79%1.05x vol
Revolution Medicines, Inc. (RVMD) moved +5.79% from $182.08 to $192.62 on 2026-06-29, reaching a new 30-day high. We che
F›
New FilingMediumMedium
Jun 220.62x vol
Revmed (RVMD) filed an 8-K on 2026-06-22, but the stock showed no immediate price movement on that date.
E›
Earnings MissHighHigh
May 6
Revmed Incorporated (RVMD) fell 24.5% after reporting EPS of -$2.29 versus the consensus estimate of -$1.84, a 24.5% mis
Showing 3 of 3 events
2. Change Timeline
| Date | Change | Price Reaction | Volume | Confidence ↓ |
|---|---|---|---|---|
| May 6 | EEarnings Miss | — | — | High |
| Jun 29 | VPrice Move Up | +5.79% | 1.05x | High |
| Jun 22 | FNew Filing | — | 0.62x | Medium |
Sort:
3. Why It Moved
1
Primary Catalyst
Earnings Miss
Revmed Incorporated (RVMD) fell 24.5% after reporting EPS of -$2.29 versus the c
2
Supporting Evidence
- Revmed Incorporated (RVMD) fell 24.5% after reporting EPS of -$2.29 ve
- Revolution Medicines, Inc. (RVMD) moved +5.79% from $182.08 to $192.62
3
Nature of Move
Company-Specific Move
RVMD outperformed peers by more than expected sector variance — move appears company-specific.
4. Peer / Sector Confirmation
| Symbol | Today | 5D | Rel. Vol | |
|---|---|---|---|---|
| RVMD | +5.79% | — | 1.54x |
Company-Specific Move. No peer data. RVMD outperformed peers by more than expected sector variance — move appears company-specific.
5. SEC Filing Watch
Jun 22High
Material event — review for impact
May 6High
Material event — review for impact
May 6Medium
Quarterly financial results
Apr 27Low
Annual proxy — exec compensation & governance
Apr 17High
Material event — review for impact
Apr 16High
Material event — review for impact
Apr 13High
Material event — review for impact
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days
6. Analyst Expectations
Consensus Target
$171.08
Median Target
$179.00
Upside to Target
-11.2%
vs $192.62
Analyst Activity — Last 90 Days
0
Upgrades
21
Maintains
0
Downgrades
Last Directional Actions
↑ Upgrade
Raymond James · Outperform → Strong Buy
Apr 10, 2024
↓ Downgrade
Goldman Sachs · Buy → Neutral
Aug 12, 2021
7. Bull vs Bear Thesis Shift
Bullish Factors
✓Strong 5.8% price move with conviction
✓Revolution Medicines, Inc. (RVMD) moved +5.79% from $182.08
Bearish Factors
✕Earnings missed expectations
✕New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Neutral / Mixed-5 / 100
8. What To Watch Next
| Date | Event | Impact | |
|---|---|---|---|
| Aug 5 | Earnings Release | High |
Confirmed dates from FMP
🔔
9. Set Alerts & Get Notified
Get notified when RVMD reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
✓ Earnings alerts
✓ Filing alerts
✓ Volume spikes
✓ Analyst actions